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Genomic Deletions Created upon
LINE-1 Retrotransposition
to the nucleus, where L1 EN cleaves genomic DNA at
a degenerate consensus target sequence (5-TTTT/A-3,
and variants of that sequence; Cost and Boeke, 1998;
Nicolas Gilbert,1,2 Sheila Lutz-Prigge,2
and John V. Moran1
Department of Human Genetics
Department of Internal Medicine Feng et al., 1996; Morrish et al., 2002). The liberated 3
hydroxyl then serves as a primer for reverse transcrip-1241 East Catherine Street
University of Michigan Medical School tion of L1 RNA by L1 RT in a process termed target-site
primed reverse transcription (TPRT; Luan and Eickbush,Ann Arbor, Michigan 48109
1995). The nascent L1 cDNA ultimately is joined to geno-
mic DNA resulting in the typical L1 structural hallmarks
(i.e., frequent 5 truncations, the presence of a 3 polySummary
(A) tail, and either small duplications or small deletions
of target site nucleotides). However, little is known aboutLINE-1 (L1) retrotransposition continues to impact the
how L1 integration is completed.human genome, yet little is known about how L1 inte-
L1s alter the genome by propagating themselves, asgrates into DNA. Here, we developed a plasmid-based
well as by mobilizing sequences derived from their 3rescue system and have used it to recover 37 new L1
flanks to new genomic locations (L1-mediated transduc-retrotransposition events from cultured human cells.
tion; Moran et al., 1999). The L1-encoded proteins alsoSequencing of the insertions revealed the usual L1
may function in trans to mediate the mobility of Alustructural hallmarks; however, in four instances, retro-
elements and processed pseudogenes, which comprisetransposition generated large target site deletions.
10% of genomic DNA (Boeke, 1997; Esnault et al.,Remarkably, three of those resulted in the formation
2000; Wei et al., 2001). Thus, either directly or by theof chimeric L1s, containing the 5 end of an endoge-
mobilization of cellular RNAs, L1 is responsible fornous L1 fused precisely to our engineered L1. Thus,
30% of human DNA. Furthermore, nonallelic DNA re-our data demonstrate multiple pathways for L1 inte-
combination events between L1s also have been impli-gration in cultured cells, and show that L1 is not simply
cated in genomic rearrangement and disease (reviewedan insertional mutagen, but that its retrotransposition
in Moran and Gilbert, 2002).can result in significant deletions of genomic se-
L1 integration is most clearly understood by compar-quence.
ing the sequences of the pre- and postintegration sites.
However, because most L1s retrotransposed in the dis-Introduction
tant past and are now fixed in the human population, it
often is difficult to obtain information about the preinte-L1s are abundant retrotransposons that comprise
gration site. Comparisons of DNA sequences between17% of human DNA (Lander et al., 2001). Most L1s
orthologous loci in humans and nonhuman primates andare retrotransposition-defective because they are 5
the identification of dimorphic L1s have yielded insighttruncated, internally rearranged, or mutated; however,
into the structures of preintegration sites (Ovchinnikov60–100 L1s remain retrotransposition-competent (RC-
et al., 2001; Sheen et al., 2000). However, mutationsL1s; Sassaman et al., 1997). RC-L1s are 6.0 kb and
and secondary DNA rearrangements occurring after thecontain a 5 untranslated region (UTR), two nonoverlap-
original retrotransposition event can complicate theseping open reading frames (ORF1 and ORF2), and a 3
analyses. Thus, the study of de novo insertions hasUTR ending in a poly (A) tail (Figure 1A; reviewed in
relied primarily on the characterization of relatively fewMoran and Gilbert, 2002). ORF1 encodes a 40 kDa nu-
disease-producing mutations.cleic acid binding protein (Hohjoh and Singer, 1996,
Here, we developed a system to rapidly clone and1997), whereas ORF2 encodes a protein with endonucle-
characterize new L1 retrotransposition events from hu-ase (L1 EN) and reverse transcriptase (L1 RT) activities
man HeLa cells. Detailed analysis of 37 events demon-(Feng et al., 1996; Mathias et al., 1991); both proteins
strated typical L1 structural hallmarks. Remarkably, ourare required for retrotransposition (Moran et al., 1996).
data also revealed that L1 retrotransposition can resultL1 retrotransposition requires the transcription of L1
in interstitial (3 kb) deletions, and that the nascentRNA, its transport to the cytoplasm, and translation of
L1-cDNA can undergo recombination with endogenousits two open reading frames (reviewed in Moran and
L1s, resulting in the formation of chimeric elements.Gilbert, 2002). Recent genetic experiments indicate the
Thus, we have uncovered mutational mechanisms byL1-encoded proteins demonstrate a cis-preference (Es-
which L1 retrotransposition continues to alter the humannault et al., 2000; Wei et al., 2001) by preferentially asso-
genome.ciating with their encoding transcript to form a ribo-
nucleoprotein particle (RNP), which is a proposed
retrotransposition intermediate (Hohjoh and Singer, Results
1996; Martin, 1991). The RNP presumably is transported
A System to Rapidly Recover New L1
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We previously tagged L1s with a selectable markeredu (N.G.)
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Figure 1. An Overview of the L1 Recovery System
(A) Rationale of the assay. The 3UTR of a human RC-L1 was tagged with a reporter cassette designed to detect retrotransposition events.
The gray rectangles indicate L1 ORF1 and L1 ORF2, respectively, and the relative positions of the endonuclease (EN), reverse transcriptase
(RT), and cysteine-rich domain (C) are indicated. The positions of the L1 promoter (P) and the SV40 late polyadenylation signal (pA) also are
indicated. The light blue rectangle indicates the mneoI gene and the lavender rectangle indicates the ColE1 bacterial origin of replication.
The relative positions of the prokaryotic/eukaryotic promoter (P) and the thymidine kinase polyadenylation signal (A) required for the expression
of the reporter gene also are shown. The mneoI gene is interrupted by an intron (-globin intron 2, indicated by the orange line) in the opposite
transcriptional orientation. SD and SA indicate the splice donor and splice acceptor sites. This arrangement ensures that a functional Neo
transcript will only be translated following L1 retrotransposition. The putative structure of a resultant retrotransposition event that confers
G418-resistance (G418R) to HeLa cells is shown at the bottom of the figure. The red lines indicate flanking genomic DNA.
(B) Flowchart of the rescue procedure. Genomic DNA was extracted from cell lines derived from either a single G418R focus or small pools
of G418R foci and the L1s were recovered using the protocol described (see Experimental Procedures).
(C) Results of RT-PCR analyses. RT-PCR was performed to monitor the presence of the spliced mneoI transcript. Molecular size standards
(1 kb plus ladder; Gibco/BRL) are indicated in Lane M. The sizes of the unspliced mneoI product (Lane 8) and the respective cDNA products also
are indicated. RT-PCR products from cells transfected with pJM101/L1.3, pK7/L1.3mneoI/ColE1, pK7/L1.3mneoI400/ColE1, pCEP4/L1.3mneoI/
ColE1, or pCEP4/L1.3mneoI400/ColE1 are indicated in Lanes 1–5, respectively. RT-PCR products from untransfected HeLa cells and no RNA
control are indicated in Lanes 6 and 7, respectively.
(D) Results of the retrotransposition assay. L1 retrotransposition was assayed using the transient retrotransposition assay (Wei et al., 2000).
The top panel displays the results from mock-transfected HeLa cells (No DNA) or HeLa cells (either 2  103 , 2  104, or 2  105 ) transfected
with pJM101/L1.3 (Sassaman et al., 1997). The bottom panel displays the results from HeLa cells (2  105 ) transfected with pK7/L1.3mneoI/
ColE1, pK7/L1.3mneoI400/ColE1, pCEP4/L1.3mneoI/ColE1, and pCEP4/L1.3mneoI400/ColE1, respectively. The relative retrotransposition effi-
ciency of each of the constructs (relative to pJM101/L1.3, a previously characterized RC-L1 [Sassaman et al., 1997]). The standard deviation
is indicated.
tance to G418 (G418R) (Moran et al., 1996). To facilitate by RT-PCR. Unexpectedly, we observed two products;
one of the predicted size (465 bp), and a smaller productthe cloning of new retrotransposition events, we modi-
fied the mneoI cassette to include a prokaryotic/eukary- (353 bp) that DNA sequencing showed resulted from the
use of a cryptic splice site present within the mneoIotic promoter, a Shine Delgarno sequence, and a ColE1
origin of replication (Figure 1A). The modified cassette cassette (Figure 1C; lanes 1, 2, and 4). Because retro-
transposition of incorrectly spliced products will not(mneoI/ColE1) was introduced either at the 3 end or
within the 3 UTR of a human RC-L1 (L1.3) (Sassaman yield G418R colonies, we created a silent mutation that
destroyed the cryptic splice site (pK7/L1.3mneoI400/et al., 1997), and the resultant constructs were sub-
cloned into a bacterial plasmid (pK7) or a mammalian ColE1 and pCEP4/L1.3mneoI400/ColE1; Figure 1C; lanes
3 and 5).expression vector (pCEP4), creating pK7/L1.3mneoI/
ColE1 and pCEP4/L1.3mneoI/ColE1. These changes Both pK7/L1.3mneoI/ColE1 and pCEP4/L1.3mneoI/
ColE1 retrotransposed in HeLa cells; though the retro-allow expression of the retrotransposed Neo gene in
both human and bacterial cells and ultimately enabled transposition efficiency was higher when L1.3 was ex-
pressed from the replication-proficient pCEP4 vectorus to recover retrotransposition events as replicating
plasmids in E. coli (Figure 1B). (Figure 1D). Constructs harboring either mneoI/ColE1or
mneoI400/ColE1 also retrotransposed at similar frequen-To determine if L1.3mneoI/ColE1 is expressed, HeLa
cells were transfected with the above plasmids, and the cies, indicating that the cryptic splice site does not affect
the retrotransposition efficiency (Figure 1D). Moreover,presence of the spliced mneoI transcript was monitored
Multiple Pathways of L1 Integration
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Figure 2. Recovered Events Demonstrate L1
Structural Hallmarks
(A) Size distributions of retrotransposition
events from pK7/L1.3mneoI/ColE1. A sche-
matic of a full-length L1 after retrotransposi-
tion from pK7/L1.3mneoI/ColE1 is indicated.
The relative positions of the L1 5UTR, L1
ORF1, L1 ORF2, the retrotransposed mneoI/
ColE1 gene, and the SV40 pA signal are indi-
cated. Lines below the figure indicate the
lengths of the retrotransposed L1s. Bold
black lines are used to indicate the relative
sizes and positions of L1s that have under-
gone either an inversion/deletion or inver-
sion/duplication. The names of the rescued
clones are indicated at the right of the figure.
Clones derived from the pK7/L1.3mneoI400/
ColE1 vectors are denoted with a subscript
400. The estimated size of the L1 poly (A) tail,
and the relative positions of the BglII (Bg),
HindIII (H), BclI (Bc), and BamHI (Ba) restric-
tion sites used in the rescue procedure also
are indicated. Notably, 2329 bp must be retro-
transposed to deliver the entire mneoI/ColE1
cassette. The lengths of the chimeric L1s can
only be estimated (see Figure 6A for a com-
plete description). The gray shading indicates
their respective 5 ends.
(B) Size distributions of retrotransposition
events from pCEP4/L1mneoI/ColE1. A sche-
matic of a full-length L1 after retrotransposition pCEP4/L1mneoI/ColE1 is indicated. Labels are the same as in Figure 3A; however, three
possible polyadenylation signals exist (SV40pA1 (pA1), L1pA (pA2), and SV40pA2 (pA3), respectively). Thus, 2328, 2474, or 2676 bp must be
retrotransposed to deliver the entire mneoI/ColE1 cassette.
the retrotransposition efficiency of pCEP4/L1.3mneoI/ 2B). Two clones (55BglII and 5HindIII) contained full-
length (8.5 kb) L1 insertions. Thirty-five clones containedColE1 was reduced by 6-fold when compared to
pCEP4/JM101/L1.3, which harbors the unmodified 5 truncated L1s. Of these, eleven clones harbored inter-
nally rearranged L1s that contain either an inversion/mneoI cassette (Sassaman et al., 1997; Wei et al., 2000).
This decrease likely is due to the increased length of deletion (9 events) or an inversion/duplication (2 events).
Examination of the DNA sequences at the inversion junc-the retrotransposed product (i.e., the 880 bp ColE1 se-
quence) needed to confer G418-resistance to HeLa tions revealed that “twin priming” might be responsible
for their formation (Ostertag and Kazazian, 2001).cells.
Thirty-six of 37 L1s ended in a poly (A) tail that ranged
in size from 3–150 nts, with an average length of 60Recovered Retrotransposition Events Resemble
Endogenous L1s residues. This is longer than the average poly (A) tail
length present at the 3 ends of Ta-subset L1 elementsTo clone the resultant retrotransposition events, geno-
mic DNA was extracted from cell lines derived from (13 adenosines; Ovchinnikov et al., 2001). Thus, our
data is consistent with the notion that dynamic mecha-either a single G418R colony or small pools (10–150) of
G418R colonies and was digested with restriction en- nisms exist (e.g., replication slippage) to shorten the L1
poly (A) tail after insertion. Each insertion derived fromzymes that do not cleave within the retrotransposed
mneoI/ColE1cassette. The digested DNA was ligated pK7/L1.3mneoI/ColE1 was polyadenylated at the sole
SV40pA site present at the 3end of the construct (Figurein dilute conditions and transformed into E.coli. KanR
colonies contained plasmids harboring the retrotrans- 2A). By contrast, insertions derived from pCEP4/
L1.3mneoI/ColE1 were polyadenylated at one of threeposed L1mneoI/ColE1 and flanking genomic DNA (Fig-
ure 1B). possible sites located at the 3 end of the L1. Three
events (8BglIIL1.3, 10BglIIL1.3, and 11BglIIL1.3) wereWe recovered 37 retrotransposition events that were
derived from pK7/L1.3mneoI/ColE1 (16 events), pK7/ polyadenylated at the native L1pA site, suggesting that
it may be functional (pA2; Figure 2B). However, it isL1.3mneoI400/ColE1 (4 events), pCEP4/L1.3mneoI/ColE1
(13 events), or pCEP4/L1.2mneoI400/ColE1 (4 events). possible that those adenosine residues were added dur-
ing TPRT, as proposed for the Drosophila I-factor non-L1.2 is a previously characterized RC-L1 (Dombroski et
al., 1991; Moran et al., 1996). As expected, Southern LTR retrotransposon (Chaboissier et al., 2000).
blot analysis of eight cell lines derived from independent
G418R colonies confirmed that the sizes of the rescued New Retrotransposition Events Occur throughout
the Genomeplasmids were comparable to the sizes of the respective
restriction fragments in genomic DNA that hybridized We used sequences flanking the L1s to identify the pre-
integration site in the human genome working draft se-with a Neo gene probe (not shown).
Sequence analysis of the 37 clones revealed that they quence (HGWD). In all but two instances (1HindIIIL1.2
and 4HindIIIL1.3; Table 1), both the 5 and 3 flankingstructurally resembled endogenous L1s (Figures 2A and
Cell
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Table 1. Distribution of the Rescued Clones
Number of
Chromosome Events Empty Site Chromosome Location/Accession Number Name of Insertion
1 4 1p13.1 / AL3914 17HindIIIL1.3
1p31.2 / AL391359 27HindIIIL1.3
1q31.1 / AC073634 3HindIIIL1.3
1q32.2 / AL355527 5HindIIIL1.3400
2 3 2p13.1 / AC025072 2BclIL1.3
2q24.1 / AC021837 9BglIIL1.3
2q32.3 / 5-AC073066, 3-AC064834 5BglIIL1.3
3 2 3p25.1 / AC023230 in CSPG5 gene intron 8BglIIL1.3
3q22.2 / AC026117 24HindIIIL1.3
4 1 4q26 / AC073559 21HindIIIL1.3
5 4 5p15.2 / AC026810 9HindIIIL1.3400
5q11.2 / 5-AC092343, 3-AC022128a in PDE4D gene intron 4HindIIIL1.3400
5q14.3 / AC044889 6BglIIL1.3
5q15 / AC018806 1HindIIIL1.3
6 2 6q15 / AC016855 10BglIIL1.3
6q23.2 / AL596188 10HindIIIL1.3
7 1 7q21.13 / AC006149 7BglIIL1.3
8 2 8p21.2 / AF263550 22HindIIIL1.3
8q22.1 / AC027242 25HindIIIL1.3
9 0
10 3 10p12.33 / AC069023 2HindIIIL1.3
10p15.3 / AC022536 23HindIIIL1.3
10q21.3 / AL133551 26HindIIIL1.3
11 3 11p15.1 / AC025620 in LDHC gene intron 5HindIIIL1.2400
11q12.1 / AP000781 in SSRP1 gene intron 1BamHIL1.3
11q12.2 / AP000781 in PRG2 gene intron 4BglIIL1.3
12 3 12p12.3 / AC022334 11HindIIIL1.3
12q22 / AC008128 50HindIIIL1.3
12q22 / AC024190 6HindIIIL1.3400
13 1 13q31.3 / AL356118 in GPC5 gene intron 11BglIIL1.3
14 2 14q11.2 / AL136419 55BglIIL1.3
14q32.2 / AL163974, 3 location unknown 1HindIIIL1.2400
15 3 15q13.2 / AC021316 in KLF13 gene intron 3HindIIIL1.2400
15q21.3 / AC008131 2BglIIL1.3
15q22.31 / AC027220 29HindIIIL1.3
16 1 16p12.2 / AC068150 52BglIIL1.3
17 0
18 0
19 0
20 0
21 1 21q22.3 / AL163301 in ADARB1 gene intron 13HindIIIL1.3
22 0
X 1 Xq22.1 / Z70280 4HindIIIL1.2400
Y NA
The features of the 37 rescued clones are listed. Column 1 indicates its chromosomal location. Column 2 indicates the number of events on
a particular chromosome. Column 3 indicates the accession number of the preintegration site and whether retrotransposition occurred into
a known gene. Column 4 indicates the name of the clone.
a There are multiple 3 map locations, also including 3-AC034225 or 3-AC092343.
sequences matched unique sequences present in the L1 EN cleavage site (Figure 3). The integration site of
1HindIIIL1.2 could not be determined because the 3HGWD with 99.5% identity. The recovered L1s were
distributed among various chromosomes, and 8 of the flanking sequence was absent from the HGWD. The
other event integrated into an atypical site, lacked a37 (19%) rescued L1s integrated into known genes
(Table 1). Thus, our data are consistent with previous poly (A) tail and was accompanied by a deletion of target
site nucleotides (Figure 3; 4HindIIIL1.3; see below).analyses, which showed that L1s can insert into genes
and that recent L1 insertions are distributed throughout Thus, it is a possible example of EN-independent retro-
transposition (Morrish et al., 2002).the genome (Lander et al., 2001; Moran et al., 1999;
Ovchinnikov et al., 2001).
Target Site Alterations Generated
upon RetrotranspositionRetrotransposition Events Predominantly
Integrate at an L1 EN Consensus Site Variable-length TSDs flanked 28 of 37 L1 retrotransposi-
tion events (Figure 3). Of these, canonical TSDs rangingComparisons of the pre- and postintegration sequences
revealed that 35 of 37 L1s integrated into a consensus from 10–16 bp flanked 18 events. By contrast, longer
Multiple Pathways of L1 Integration
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Figure 3. L1s Predominantly Integrate at an
L1 EN Cleavage Site
Names of the rescued clones are indicated
on the left. The “gap” in the center of the
alignment indicates the bottom strand cleav-
age site. Black shading indicates nucleotides
in agreement with the degenerate consensus
L1 EN cleavage site sequence, which is indi-
cated above the alignment (3-A/TTTT-5).
Gray shading indicates stretches of pyrimi-
dines or purines that are 5 or 3 of the bottom
strand cleavage site, respectively. The sizes
of the TSDs or deletions are indicated at the
right of the figure. Underlining indicates nu-
cleotides present in the TSD. The sequences
of the long TSDs are available upon request.
The asterisk indicates an L1 insertion (4Hind-
IIIL1.3) that lacks a poly (A) tail. This L1 se-
quence also contains two ambiguous nucleo-
tides (GT) that can be derived from either the
L1 or the preintegration site. Thus, there are
three possible cleavage sites (5-GCTG/C, 5-
AGCT/G, or 5-GAGC/T). The integration site
of 1HindIIIL1.2 could not be determined (see
text for details).
TSDs ranging from 39–135 bp flanked nine events. The Interstitial Deletions Are Created
upon Retrotranspositionlonger TSDs are somewhat unorthodox, though TSDs
Sequence comparisons between the pre- and postinte-of up to 60 bp have been identified in the HGWD (S.T.
gration sites of 5BglIIL1.3 suggested that L1 retrotrans-Szak and J.D. Boeke, personal communication). Finally,
position resulted in a 71 kb deletion of target-site se-in one event (8BglIIL1.3), a TSD of 6319 bp flanked L1,
quence (Figure 4A). To determine if the deletion existedand its generation resulted in the partial duplication of
prior to retrotransposition, we conducted a series ofthe first intron of the CSPG5 gene. Thus, L1 retrotranspo-
PCR amplifications on genomic DNA from either naı¨vesition can generate large TSDs. However, DNA recombi-
HeLa cells or a polyclonal cell line containing thenation between the TSDs may render these events un-
5BglIIL1.3 insertion (SLP5BglII; Figure 4B). PCR reac-stable during genome evolution, which is similar to the
tions using the 5 flank/3 flank primers only amplifiedsituation observed for the long terminal repeats of en-
the predicted 3.2 kb product from SLP5BglII DNA; wedogenous retroviruses (Liao et al., 1998).
never amplified a 221 bp product from naı¨ve HeLa cells,Nine events lacked TSDs (Figure 3). In one event
which would be expected if a deletion occurred prior to
(2HindIIIL1.3), retrotransposition neither resulted in a gain
retrotransposition.
nor loss of target site nucleotides; thus, it is an example To confirm that the HGWD in this interval was assem-
of conservative retrotransposition. In eight events, retro- bled correctly and that these sequences were present
transposition resulted in the deletion of target site nucle- in HeLa cells, we performed PCR reactions with the
otides. Four events (2BclIL1.3, 11BglIIL1.3, 10HindIIIL1.3, following primers: (1) 5 flank/5R; (2) 5 flank/5R6K; (3)
and 26HindIIIL1.3) were accompanied by small deletions 5 flank/5R12K; (4) 3F12K/3 flank; (5) 3F6K/3 flank; or
that ranged in size from 2–47 bp, which is in accord with (6) 3F/3 flank. In every case, we amplified the expected
previous in vivo and in vitro studies (reviewed in Moran sized products from both HeLa and SLP5BglII cells (see
and Gilbert, 2002). The remaining events (5BglIIL1.3, Figure 4B). Thus, our data indicate that retrotransposi-
3HindIIIL1.3, 4HindIIIL1.3, and 1HindIIIL1.2) had novel tion resulted in a large target site deletion of at least 24
kb (derived by adding the sizes of the PCR productsstructures, and each is characterized below.
Cell
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Figure 4. L1 Retrotransposition Can Result in Interstitial Deletions
(A) Schematic representation of the pre- and postintegration sequences. The structures of the preintegration site present in the HGWD and
the postintegration site of 5BglIIL1.3 are indicated. Black lines indicate sequences present in both the pre- and postintegration sites. The
thick gray lines indicate sequences that are present only in the preintegration site. The horizontal arrows indicate the relative positions of
PCR primers. The vertical arrow indicates the L1 EN cleavage site, where integration began. The rectangles indicate the structure of the 2.9
kb retrotransposed L1mneoI/ColE1.
(B) PCR analyses. PCR reactions confirmed that at least 24 kb of DNA was deleted upon L1 retrotransposition. PCR primers are indicated
above the gel. M indicates 1 kb plus molecular weight markers (Gibco/BRL). P indicates PCR products from SLP5BglII DNA, which contains
the 5BglIIL1.3 insertion. H indicates PCR products from naı¨ve HeLa cell DNA. O indicates PCR with no DNA. As an additional control, we
demonstrated that PCR reactions using the 5 flank/173NEOAS primer pair only amplified the expected sized product in SLP5BglII DNA.
Sequencing of this product demonstrated that it was identical to the analogous segment in 5BglIIL1.3.
amplified by 5 flank/5R12K (12 kb) and 3 flank/3F12K integrated into repeat rich sequences that were incom-
(12 kb)). However, based upon the HGWD, the deletion pletely assembled. PCR reactions using primers flanking
may be 71 kb. each insertion amplified the resultant integration events
(not shown); however, we could not amplify the preinte-
gration site from naı¨ve HeLa cell DNA. Thus, our dataChimeric L1s Are Created
suggest that formation of these chimeric L1s was ac-upon Retrotransposition
companied by a concomitant deletion of target site nu-Three retrotransposition events (3HindIIIL1.3, 4HindIIIL1.3,
cleotides, though we could not determine the sizes ofand 1HindIIIL1.2) resulted in the generation of chimeric
the respective deletions.L1s that contain the 5 end of an endogenous L1 pre-
By contrast, 3HindIIIL1.3 integrated into a fully assem-cisely joined to the corresponding position of the L1mneoI/
bled contig, and both PCR and Southern blot analysesColE1 (Figure 5A). To confirm that the chimeric L1s were
confirmed that the formation of the chimeric L1 resultednot generated by homeologous DNA recombination in
in the concomitant deletion of 3.1 kb of intervening se-E. coli during the rescue procedure, we conducted a
quence (see Figures 5B–5E). Notably, we were unableseries of PCR reactions on genomic DNA from clonal
to amplify a PCR product with 3HindIIIint/173NEOAScell lines harboring the respective retrotransposition
from genomic DNA derived from either the original poly-events. In each instance, PCR with a 5 flanking DNA
clonal cell line containing the 3HindIIIL1.3 insertion orprimer and 173NEOAS amplified products of the same
from two clonal cell lines derived from the original poly-size as those present in the rescued clone, and we con-
clonal cell line (see Figure 5B). Thus, our data indicatefirmed that the sequences of the PCR products were
that the chimeric L1 present in 3HindIIIL1.3 did not resultidentical to those in the rescued clones (Figure 5A and
via a two step process in which a tandemly integratednot shown).
L1 subsequently was resolved by homeologous DNAComparisons of the DNA sequences flanking the chi-
recombination, but that it most likely was generatedmeric L1s with the respective preintegration sites in the
HGWD revealed that both 4HindIIIL1.3 and 1HindIIIL1.2 during retrotransposition.
Multiple Pathways of L1 Integration
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Figure 5. L1 Retrotransposition Can Result in Chimeric L1s
(A) Schematic representation of three chimeric L1s. The structures of 3HindIIIL1.3, 4HindIIIL1.3, and 1HindIIIL1.2 are indicated by the rectangles.
Different shading indicates the junction between the endogenous L1 (gray rectangle) and the retrotransposed L1 (white rectangle). Lollipops
indicate the relative positions of nucleotide sequence changes that differentiate the endogenous L1 from the retrotransposed L1mneoI/ColE1.
The white lollipop indicates the position of a nucleotide specific to L1.3mneoI/ColE1 (see description in 5E). There are 23 nucleotide differences
in a 374 bp segment between 1HindIIIL1.2 and pL1.2mneoI/ColE1. Arrows indicate the relative position of PCR primers.
(B) Schematic representation of the pre- and postintegration sequences of 3HindIIIL1.3. The structures of the preintegration and the postintegra-
tion site of 3HindIIIL1.3 are shown. Labels are as in Figure 5A and the relative positions of the restriction sites are indicated. Also indicated
are sequences deleted upon retrotransposition (3114 bp; the 5 end of the deletion size was derived from the position of the first nucleotide
polymorphism that exists between 3HindIIIL1.3 and pL1.3mneoI/ColE1). The sizes of the predicted PCR products generated from the 5 flank
and 3 flank primer pairs for both the preintegration (3997 bp) and postintegration (4790 bp) site and the relative positions of the 5 and 3
probes used in Southern blot analysis also are indicated. Primer 3HindIIIint was used to determine whether tandemly integrated L1s were
present.
(C) PCR analysis. Amplification of the pre-and postintegration sites confirmed that 3.1 kb of DNA was deleted upon the creation of the chimeric
L1. PCR primers are indicated above the gel and their relative location is shown in Figure 5B. M indicates 1 kb plus molecular weight markers
(Gibco/BRL). P1 and P2 indicate PCR products from the DNA of two different clonal cell lines containing 3HindIIIL1.3. H1 and H2 indicate
PCR products generated either from HeLa cell DNA or from 50HindIIIL1.3 DNA, which contains a different (i.e., irrelevant) retrotransposed L1
sequence. O indicates PCR with no DNA.
(D) Southern analysis. Genomic DNA was isolated from naı¨ve HeLa cells (H1) or from the two clonal cell lines containing the 3HindIIIL1.3
insertion (P1 and P2). 10 g of DNA was restricted with HindIII and was subjected to Southern blot analysis using either the 1.2 kb 5 probe
or the 581 bp 3 probe. Lane C contains DNA from the 3HindIIIL1.3 rescued clone, which was linearized with HindIII. It serves as both a size
and hybridization control. The sizes of the respected fragments are indicated.
(E) Nucleotide sequence at the junction of 3HindIIIL1.3. Black shading indicates nucleotides diagnostic for the endogenous L1, whereas the
gray shading indicates nucleotides diagnostic for the retrotransposed L1. The asterisk indicates an engineered sequence change in pL1.3mneoI/
ColE1, which removes a BamHI site. SNP typing showed that the endogenous L1 contains the BamH1 site (data not shown). L1 nucleotides
are numbered according to a reference L1 (L1.2; Dombroski et al., 1991). Underlining indicates the TSD flanking the endogenous L1.
Discussion nisms by which L1 retrotransposition continues to alter
the human genome. Because our system allows the
examination of retrotransposition events soon after theirIn summary, we developed a high-throughput system
to characterize new L1 retrotransposition events from insertion, the possible effects of negative selection, DNA
sequence mutation, and secondary DNA rearrangementscultured cells, and as a result, have discovered mecha-
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Figure 6. Models for L1 Integration
(A) Target site alterations created upon L1
retrotransposition. A model proposing how
L1 retrotransposition results in various target
site alterations (i.e., TSDs, blunt insertions,
or small deletions) is shown. Each event is
initiated by L1 EN cleavage of the bottom
strand followed by L1 cDNA synthesis (repre-
sented by the orange arrow). The position of
top strand cleavage can create a 3 overhang
(left), no overhang (i.e., a blunt end; middle),
or a 5 overhang (right). The proposed inter-
mediate can be recognized as a substrate by
the host repair machinery resulting in 5-3
exonucleolytic processing. Plus () strand L1
cDNA synthesis by either L1 RT or host en-
zymes followed by recombinational repair
would lead to the final product. This model
accounts for the generation of TSDs (indi-
cated by the light blue rectangles on the left
side), conservative insertions (middle) or
small deletions (right side).
(B) Generation of other target site alterations.
Modifications of the above model explain
how retrotransposition can result in the for-
mation of chimeric L1s, large deletions, or
long TSDs. Details are provided in the text.
L1 cDNA is indicated in orange. TSDs are
indicated by the light blue rectangles. The
black rectangle in the left panel indicates an
endogenous L1. ENDO indicates a proposed
substrate for a 3 processing endonuclease.
The pink lines in the center panel indicate
endogenous DNA sequences located up-
stream of the L1 integration site. The red lines
in the right panel indicate endogenous DNA
sequences located downstream of the L1 in-
tegration site. A gap is used to indicate the
position of a double-strand break or single-
strand nick. The dark blue arrow indicates
the initiation site of second () strand cDNA
synthesis.
are minimized. Thus, we can accurately characterize a L1 EN consensus site, whereas the other (4HindIIIL1.3)
likely integrated into an existing DNA lesion via anboth the pre- and postintegration sites.
All the events characterized in our study had L1 struc- EN-independent pathway (Morrish et al., 2002). Interest-
ingly, though there is a clear L1 EN consensus “bottomtural hallmarks. The majority of events (35 of 37) were
5 truncated or contained internal rearrangements; how- strand” cleavage site, our data demonstrates that there
is little or no target site preference for top strand cleav-ever, two retrotransposition events were 8.5 kb in length.
Thus, we conclude that engineered L1s can retrotrans- age. Thus, L1 EN either is an unusual enzyme that only
displays sequence specific cleavage for a single DNApose full-length copies of themselves. Moreover, be-
cause both events contained an intact 5UTR, but lacked strand, or a yet undiscovered enzyme performs second
strand cleavage (see Figure 6).flanking vector sequences, our data provide experimen-
tal support that L1 transcription is initiated from the first An unexpected outcome of our study is that L1 retro-
transposition can result in a variety of target site alter-nucleotide of the 5UTR (Swergold, 1990). Finally, we
note that three internally rearranged L1s were 6 kb in ations. How these modifications are generated requires
further study. However, we propose that each event islength; thus, 5 of 37 (14%) insertions retrotransposed
a “genomic equivalent” of L1 DNA. This is in general initiated by an L1 EN cleavage of the bottom strand
followed by TPRT. The duplication, conservation, or de-agreement with previous studies, which demonstrated
that 2 of 13 (15%) mutagenic L1 insertions are full- letion of target site nucleotides then results from the
variable position of top strand cleavage (Figure 6A),length (reviewed in Moran and Gilbert, 2002).
Our data provides strong experimental support for the which by analogy to the R2 non-LTR retrotransposon
of Bombyx mori, will occur after the initiation of ()hypothesis that L1 EN generates a sequence specific
endonucleolytic nick in the bottom strand of the target strand cDNA synthesis by TPRT (Luan and Eickbush,
1995; Luan et al., 1993). We propose that the resultantsequence to initiate L1 retrotransposition. Thirty-five of
36 characterized retrotransposition events integrated at intermediate can be recognized as a substrate by the
Multiple Pathways of L1 Integration
323
host repair machinery and subsequently undergoes 5- ments (Carroll et al., 2001; Kass et al., 1995), and we
3 exonucleolytic processing. Plus () strand L1 cDNA speculate that many of those events occurred by Alu
synthesis by either L1 RT or host enzymes followed cDNA-mediated recombination. Finally, de novo poly (A)
by recombinational repair would then lead to the final tails have been found at the junctions of mutagenic
integration product. According to our model, top strand deletions, which resulted in either breast cancer (a 6.2
cleavages downstream of the initial endonucleolytic nick kb deletion) or Alport syndrome (a 13.4 kb deletion;
ultimately will lead to the generation of TSDs (Figure Segal et al., 1999; Wang et al., 2001). In both instances,
6A; left). By contrast, top strand cleavages in direct the poly (A) tail integrated at an L1 EN consensus cleav-
opposition or upstream of the initial endonucleolytic nick age site. Thus, it is possible that L1 or Alu retrotransposi-
will result either in conservative insertions or the genera- tion led to the formation of these deletions.
tion of small deletions (Figure 6A; center and right, re- In closing, we have uncovered mechanisms by which
spectively). L1 retrotransposition continues to alter the human ge-
The other observed rearrangements can be explained nome, and have demonstrated that L1 is not simply an
by simple modifications of the above model (Figure 6B). insertional mutagen. Indeed, our data highlight path-
For example, chimeric L1s can be generated by single- ways by which L1 retrotransposition can act to reduce
strand annealing if the () strand L1 cDNA undergoes genome size and provide additional mutational mecha-
heteroduplex formation and DNA recombination with a nisms by which retrotransposition can affect tumor and
homeologous L1 located upstream of the integration perhaps germ cells.
site. Processing of the top strand 3 overhang and com-
pletion of integration by recombinational repair (as
Experimental Proceduresabove) will result in a chimeric L1 and the concomitant
deletion of intervening genomic DNA (Figure 6B; left).
Oligonucleotides and Recombinant PlasmidsThis mechanism can account for the mosaic pattern of
All oligonucleotide sequences are available at upon request or can
coconversion observed in the chimeric L1s (Figure 5A; be accessed at www.med.umich.edu/hg/RESEARCH/FACULTY/
Szostak et al., 1983), the formation of hybrid L1s (Hay- Moran/moranweb.htm.
ward et al., 1997), and the generation of new L1 subfamil- pNGneoSD contains the mneoI cassette with a Shine Delgarno
(SD) sequence. The SD sequence was introduced upstream of theies (Saxton and Martin, 1998). By comparison, the large
mneoI initiator codon by PCR. A 1.8 kb product was amplified fromdeletion observed in 5BglIIL1.3 can be generated if ()
pmneoI using the BamNeo and MluSDal primers. The product, whichstrand L1 cDNA invades a double-strand break up-
contained the SD sequence, was digested with MluI and BamHI andstream of the initial integration site (Figure 6B; middle).
was used to replace the analogous fragment from pmneoI.
Likewise, large TSDs can be generated if the () strand pNGneoEM7 is a modified version of pNGneoSD that contains
L1 cDNA synthesis is initiated from the 3 hydroxyl resi- the bacterial EM7 promoter. The 79 bp EM7 promoter from pHook3
due of a single-strand nick downstream of the initial L1 (Invitrogen) was amplified using the EM75 and EM73 primers. The
product was digested with MluI and was introduced into the MluIintegration site (see Figure 6B; right).
site of pNGneoSD.Future studies will determine whether the formation
pK7 is a plasmid containing the modified mneoI cassette fromof long TSDs, interstitial deletions, and the generation
pNGneoEM7. The 1033 bp Amp gene from pBluescript (Stratagene)of chimeric L1s occur at high frequencies naturally.
was amplified using the AscAmp5 and BamNotAmp3 primers. The
However, the cell culture retrotransposition system has 894 bp ColE1 origin from pBK-RSV (Stratagene) was amplified using
accurately recapitulated many aspects of L1 biology, the R1ColE5 and PstColE3 primers. The 249 bp SV40 polyadenyl-
including the phenomena of L1-mediated transduction ation signal from pBK-RSV (Stratagene) was amplified using the
and processed pseudogene formation (Esnault et al., PstSV405 and AscSV403 primers. pK7 was created by ligating
the AscI-BamHI Amp fragment, the EcoRI and PstI ColE1 fragment,2000; Moran et al., 1999; Wei et al., 2001). Moreover,
the PstI and AscI SV40pA fragment, and the EcoR1 and BamHIthe accompanying paper by Symer et al. (2002 [this
fragment from pNGneoEM7.issue of Cell]) provides evidence for similar L1-induced
pK7400 was generated as above, but contains a silent mutationrearrangements in a HCT116 colon cancer cell line.
that destroyed the crypic splice site present in the mneoI gene.
Thus, we hypothesize that the characterization of addi- Site-directed mutagenesis was performed using the QuikChange
tional disease-producing de novo L1 insertions ulti- XL Site-Directed Mutagenesis Kit (Stratagene) using the SDM400S
mately will uncover similar structural rearrangements. and SDM400AS primers.
pK7/L1.3mneoI/ColE1 contains the mneoI/ColE1 cassette at theIndeed, recent studies have shown that mutagenic TF
end of the L1.3 3UTR. pJM101/L1.3 no neo was digested with NotIsubfamily L1 insertions into the disabled 1 and titin
and BamHI and the resultant fragment was cloned between the NotIgenes of mouse resulted in deletions of 2.7 kb and 779
and BamHI sites of pK7.bp, respectively (Garvey et al., 2002; Kojima et al., 2000).
pK7/L1.3mneoI400/ColE1 contains the mneoI400/ColE1 cassette atThe generation of deletions and chimeric elements the end of the L1.3 3UTR. It was cloned as above.
upon retrotransposition may not be unique to L1s. For pCEP4/L1.3mneoI/ColE1 contains the mneoI/ColE1 cassette
example, the retrotransposition of a “young” Alu Y ele- within the L1.3 3UTR. pK7 was digested with BamH1 and AscI. The
ment into the CMP-N-acetylneuraminic acid hydroxy- ends were made blunt with 6 units of T4 DNA polymerase (NEB) and
100M dNTP in 1 T4 DNA polymerase buffer (NEB). The resultantlase gene resulted in the replacement of an “older”
product was subcloned into the SmaI site present in the 3UTR ofAluSq element and the deletion of an internal exon of
pJM101/L1.3 no neo.that gene (Hayakawa et al., 2001). Similarly, retrotrans-
pCEP4/L1.3 mneoI400/ColE1 contains the mneoI400/ColE1 cassetteposition of a young Alu Yb9 element into the APC gene
within the L1.3 3UTR. It was cloned as above using pK7400resulted in the creation of a chimeric element, whose 5 pCEP4/L1.2 mneoI400/ColE1 contains the mneoI400/ColE1 cassette
end consists of an older Alu Sq element (Su et al., 2000). within the L1.2 3UTR. Swapping the NotI-BstZ17I fragment from
There also are numerous examples of gene conversion pJM101/L1.2 with the corresponding fragment from pCEP4/L1.3
mneoI400/ColE1 created it.in which young Alu elements replaced older Alu ele-
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DNA Preparation PCR Amplification of the Integration Sites
of the Chimeric L1sPlasmid DNAs were purified on Qiagen midi prep columns (Qiagen).
Rescued plasmids were purified using Wizard S/V miniprep kits The preintegration site of 3HindIIIL1.3 was amplified using 3HindIII5
flank and 3HindIII3 flank as primers. The postintegration sites of(Promega). HeLa genomic DNA was isolated using either the Blood
and Cell Midi prep kit (Qiagen) or the Cell and Tissue DNA isolation 3HindIIIL1.3, 4HindIIIL1.3 and 1HindIIIL1.2 were amplified using a
respective 5 flank primer and 173NEOAS as primers. Amplificationkit (Puregene, Gentra).
conditions were the same as for 5BglIIL1.3 (see above) and were
performed on genomic DNA from clonal cell lines containing theL1 Retrotransposition Assay
respective insertions. The sequence of the respective chimeric L1HeLa cells were grown at 37C in an atmosphere containing 7%
was verified by sequencing the PCR product.carbon dioxide and 100% humidity in Dulbecco’s modified Eagle
medium (DMEM) lacking pyruvate (Gibco BRL). DMEM was supple-
Southern Blot Analysismented with 10% fetal bovine calf serum and 1 Penicillin-Strepto-
Southern blotting was performed using the protocol provided in themycin-L-glutamine (a 100  stock is sold by Gibco BRL). Cell pas-
Nytran membrane book (Schleicher and Schuell). 10 g of genomicsage and cloning (by either limiting dilution or colony lifting) was
DNA was digested with HindIII and was resolved on a 0.8% agarose/performed using standard techniques. Retrotransposition was mon-
TAE gel. After denaturing and neutralizing, the DNA was transferreditored using the transient retrotransposition assay (Wei et al., 2000).
to a Nytran SuPer Charge membrane (Schleicher and Schuell) using
20  SSC buffer at pH 7.0 (SSC is 150 mM NaCl and 15 mM sodiumRT-PCR
citrate). The membranes were prehybridized for 3 hr at 42C in HybTotal RNA was extracted using TRIZOL (Invitrogen) three days post-
buffer (5  SSC, 2% Blocking Reagent [Roche], 50% formamide,transfection. 50 g of RNA in 25 l of 1 buffer (20 mM Tris-HCl,
7% SDS, 0.1% N-laurosarcosine and 50 mM sodium phosphate2 mM MgCl2, and 50 mM KCl) were treated with 2 units of DNase 1
buffer, [pH 7.0]). Probes (as indicated in Figure 5D) were obtained(Gibco/BRL). After incubation for 1 hr at 37C, the enzyme was
by digesting the rescued 3HindIII plasmid with HindIII and HpaI (5inactivated by a 20 min incubation at 65C. 10 g of treated RNA
probe) or HindIII and XbaI (3 probe). The digested DNA fragmentsin 20 l of 1 buffer (50 mM Tris-HCl, 8 mM MgCl2, 37.5 mM KCl,
were resolved on 0.7% agarose/ethidium bromide gels, were puri-1 mM dithiothreitol, 1 mM of each dNTP, and 50 pmol oligo dT15)
fied using a gel extraction kit (Qiagen), and were random primewas reverse transcribed using 25 U of AMV RT (Roche) for 1 hr at
labeled with [	-32P]dCTP using the Redi-prime II labeling system42C. 2l of the RT product was used as a template in PCR reactions
(Amersham). Unincorporated counts were removed by centrifuga-with 437NEOS and 1785NEOAS using the following cycling condi-
tion through a Microspin G50. Three million counts/ml of hybridiza-tions (one cycle 94C for 3 min; 30 cycles: 94C for 10 s, 60C for
tion buffer were used in hybridizations, which were carried out over-30 s, 72C for 1 min; one cycle 72C for 10 min). The products were
night at 42C in 1 Hyb buffer. Blots were washed twice in 2 resolved on 1.0% agarose-ethidium bromide gels.
SSC, 0.5% SDS at 25C for 30 min; once in 0.1  SSC, 0.5% SDS
at 37C for 45 min; and once in 0.1  SSC, 0.5% SDS at 68C forRescue Procedure
90 min. The washed filter was then exposed on X-OMAT film for 1810 g of DNA was digested overnight with HindIII, BglII, BclI or
hr at 80C.BamHI (NEB). The enzyme was either heat inactivated or removed
using the Wizard DNA Clean-up Kit (Promega). The resultant frag-
Acknowledgmentsments were ligated overnight at 14C in a 500 l volume with T4 DNA
ligase (2,400 U; NEB). Ligations were concentrated by centrifugation
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